by María Álvarez | Oct 14, 2019 | Investors, R+D
The Board of Directors of ENISA has approved the granting of a participatory loan to the company Derma Innovate, S.L.
by María Álvarez | Jan 15, 2019 | Investigación, Investors, R+D
A new technology based on a laser device allows the development of new therapies in skin and hair regeneration Derma Innovate, S.L., is a biotechnology company owned by Canaan Research & Investment, S.L., aimed at developing new solutions and innovative...
by María Álvarez | Jan 2, 2019 | Investors, R+D
26/11/2018 Derma Innovate, biotech company focused on development of new lines of Innovative products in skin and hair regeneration, has presented its Project in the Investment Forum in Health, which was celebrated the last November 26th in Banco Sabadell Auditorium,...
by María Álvarez | Dec 11, 2018 | Investors, R+D
Europa Press | December 05, 2018 The biotechnology company Derma Innovate has opened a round of funding in the crowdfunding platform ‘Capital Cell’, which aims to raise 400,000 euros to be able to validate their clinical trials on skin and hair...
by María Álvarez | Aug 24, 2018 | R+D
Isquaemia Biotech, a company owned by Canaan Reserch & Investment, an investment company specializing in the biotechnology sector, together with the Autonomous University of Madrid and the Higher Council of Scientific Research have signed a license agreement for...
by María Álvarez | Aug 24, 2018 | R+D
09/10/2015 Researchers of the Experimental Dermatology and Cutaneous Biology Group of the Ramón y Cajal Institute of Health Research -IRYCIS- of the Ramón y Cajal University Hospital have shown for the first time, how the production of reactive oxygen species in a...
